BR112018075667B1 - Métodos para separar um oligonucleotídeo alvo de uma mistura contendo o oligonucleotídeo alvo e uma impureza relacionada com o produto - Google Patents

Métodos para separar um oligonucleotídeo alvo de uma mistura contendo o oligonucleotídeo alvo e uma impureza relacionada com o produto Download PDF

Info

Publication number
BR112018075667B1
BR112018075667B1 BR112018075667-9A BR112018075667A BR112018075667B1 BR 112018075667 B1 BR112018075667 B1 BR 112018075667B1 BR 112018075667 A BR112018075667 A BR 112018075667A BR 112018075667 B1 BR112018075667 B1 BR 112018075667B1
Authority
BR
Brazil
Prior art keywords
impurity
target oligonucleotide
product
approximately
oligonucleotide
Prior art date
Application number
BR112018075667-9A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112018075667A2 (pt
Inventor
Robert S. Gronke
Ratnesh S. Joshi
Original Assignee
Biogen Ma, Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Ma, Inc filed Critical Biogen Ma, Inc
Publication of BR112018075667A2 publication Critical patent/BR112018075667A2/pt
Publication of BR112018075667B1 publication Critical patent/BR112018075667B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/30—Partition chromatography
    • B01D15/305—Hydrophilic interaction chromatography [HILIC]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/32—Bonded phase chromatography
    • B01D15/325—Reversed phase
    • B01D15/327—Reversed phase with hydrophobic interaction
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424—Elution mode
    • B01D15/426—Specific type of solvent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112018075667-9A 2016-06-14 2017-06-13 Métodos para separar um oligonucleotídeo alvo de uma mistura contendo o oligonucleotídeo alvo e uma impureza relacionada com o produto BR112018075667B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662349970P 2016-06-14 2016-06-14
US62/349,970 2016-06-14
US201762492402P 2017-05-01 2017-05-01
US62/492,402 2017-05-01
PCT/US2017/037126 WO2017218454A1 (en) 2016-06-14 2017-06-13 Hydrophobic interaction chromatography for purification of oligonucleotides

Publications (2)

Publication Number Publication Date
BR112018075667A2 BR112018075667A2 (pt) 2019-04-09
BR112018075667B1 true BR112018075667B1 (pt) 2024-02-20

Family

ID=59216016

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018075667-9A BR112018075667B1 (pt) 2016-06-14 2017-06-13 Métodos para separar um oligonucleotídeo alvo de uma mistura contendo o oligonucleotídeo alvo e uma impureza relacionada com o produto

Country Status (11)

Country Link
US (3) US10947262B2 (cg-RX-API-DMAC7.html)
EP (1) EP3468981B1 (cg-RX-API-DMAC7.html)
JP (1) JP7075359B2 (cg-RX-API-DMAC7.html)
KR (1) KR102461234B1 (cg-RX-API-DMAC7.html)
CN (1) CN109641928B (cg-RX-API-DMAC7.html)
AU (1) AU2017284202B2 (cg-RX-API-DMAC7.html)
BR (1) BR112018075667B1 (cg-RX-API-DMAC7.html)
ES (1) ES2988362T3 (cg-RX-API-DMAC7.html)
IL (1) IL263639B (cg-RX-API-DMAC7.html)
MX (1) MX2018015654A (cg-RX-API-DMAC7.html)
WO (1) WO2017218454A1 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016040748A1 (en) 2014-09-12 2016-03-17 Ionis Pharmaceuticals, Inc. Compositions and methods for detection of smn protein in a subject and treatment of a subject
AR102198A1 (es) 2014-10-09 2017-02-08 Regeneron Pharma Proceso para reducir partículas subvisibles en una formulación farmacéutica
AU2017312785B2 (en) 2016-08-16 2024-10-10 Regeneron Pharmaceuticals, Inc. Methods for quantitating individual antibodies from a mixture
KR102759512B1 (ko) 2016-10-25 2025-02-03 리제너론 파아마슈티컬스, 인크. 크로마토그래피 데이터 분석을 위한 방법 및 시스템
WO2019060062A1 (en) 2017-09-19 2019-03-28 Regeneron Pharmaceuticals Inc. METHODS OF REDUCING PARTICLE FORMATION AND COMPOSITIONS FORMED THEREFROM
TWI919355B (zh) 2018-07-02 2026-03-21 美商里珍納龍藥品有限公司 自混合物製備多肽之系統及方法
WO2020072062A1 (en) * 2018-10-04 2020-04-09 Gsw Creative Corporation Portable charging case
EA202192422A1 (ru) 2019-03-05 2021-12-09 Ридженерон Фармасьютикалз, Инк. Человеческий сывороточный альбумин в составах
CN110066789B (zh) * 2019-05-17 2021-04-20 通用生物系统(安徽)有限公司 一种长链dna引物的hplc纯化改进的方法
CN114025805B (zh) * 2019-06-07 2025-01-24 达因疗法公司 制备蛋白质-寡核苷酸复合物的方法
AU2021225957A1 (en) 2020-02-28 2022-09-08 Ionis Pharmaceuticals, Inc. Compounds and methods for modulating SMN2
WO2022187312A1 (en) * 2021-03-02 2022-09-09 Ionis Pharmaceuticals, Inc. Purification methods for oligomeric compounds
JP7897322B2 (ja) * 2022-09-07 2026-07-29 株式会社日本触媒 核酸の製造方法、不純物の除去方法及び不純物が少ない核酸
CN117050120A (zh) * 2022-12-09 2023-11-14 苏州赛分科技股份有限公司 一种纯化小干扰rna的柱层析法
WO2024175051A1 (zh) * 2023-02-23 2024-08-29 奥安医药(苏州)有限公司 一种疏水层析制备寡核苷酸的方法
WO2025149349A1 (en) 2024-01-09 2025-07-17 Cytiva Bioprocess R&D Ab Method for separating nucleic acid molecules
WO2025234897A1 (ru) * 2024-05-07 2025-11-13 Акционерное общество "ГЕНЕРИУМ" Способ получения тиофосфатных олигонуклеотидов для терапевтического применения

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60104097A (ja) * 1983-11-08 1985-06-08 Sagami Chem Res Center Dνaの精製方法
DE3433649A1 (de) * 1984-09-13 1986-03-20 Gesellschaft für Biotechnologische Forschung mbH (GBF), 3300 Braunschweig Verfahren zur aufreinigung synthetischer oligonucleotide
US6087491A (en) * 1993-01-08 2000-07-11 Hybridon, Inc. Extremely high purity oligonucleotides and methods of synthesizing them using dimer blocks
CN1155887A (zh) * 1994-07-05 1997-07-30 海布里顿公司 用deae-5pw阴离子-离子交换色谱和疏水作用色谱纯化硫代磷酸寡脱氧核苷酸
WO1996001268A1 (en) * 1994-07-05 1996-01-18 Hybridon, Inc. Purification of oligodeoxynucleotide phosphorothioates using deae 5pw anion ion-exchange chromatography and hydrophobic interaction chromatography
JP2001520660A (ja) * 1997-04-21 2001-10-30 プロリゴ・エルエルシー オリゴヌクレオチドの溶液相合成方法
JP2000035423A (ja) 1998-05-11 2000-02-02 Tosoh Corp 液体クロマトグラフィ―による核酸の分離法
CN1264854C (zh) * 1999-05-28 2006-07-19 坎布雷科斯生物科学巴尔的摩公司 Dna纯化方法和纯化的dna
PT102491B (pt) * 2000-07-10 2003-02-28 Inst Superior Tecnico Processo para producao e purificacao de dna plasmidico
US7345163B2 (en) 2002-08-28 2008-03-18 Quiatech Ab Process for separating and deprotecting oligonucleotides
CA2504694C (en) 2002-11-05 2013-10-01 Isis Pharmaceuticals, Inc. Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
US20050019951A1 (en) * 2003-07-14 2005-01-27 Gjerde Douglas T. Method and device for extracting an analyte
DK1661905T3 (da) 2003-08-28 2012-07-23 Takeshi Imanishi Hidtil ukendte syntetiske nukleinsyrer af N-O-krydsbindingstype
MXPA06011568A (es) * 2004-04-19 2006-12-20 Centelion Metodo para purificar adn plasmidico.
PT2548560E (pt) 2005-06-23 2015-09-22 Isis Pharmaceuticals Inc Composições e métodos de modulação da excisão-união de smn2
DE602007009487D1 (de) 2006-01-27 2010-11-11 Isis Pharmaceutical Inc 6-modifizierte bicyclische nukleinsäureanaloga
SG2014015010A (en) * 2008-04-30 2014-05-29 Gradalis Inc Highly pure plasmid dna preparations and processes for preparing the same
KR20220084437A (ko) 2009-06-17 2022-06-21 바이오젠 엠에이 인코포레이티드 대상에게서 smn2 스플라이싱을 조정하기 위한 조성물 및 방법
HUE050704T2 (hu) 2014-04-01 2020-12-28 Biogen Ma Inc Összetételek a SOD-1 expressziójának modulálására

Also Published As

Publication number Publication date
AU2017284202A1 (en) 2019-01-17
US10947262B2 (en) 2021-03-16
JP2019518759A (ja) 2019-07-04
KR20190018467A (ko) 2019-02-22
AU2017284202B2 (en) 2021-11-04
KR102461234B1 (ko) 2022-10-28
CN109641928B (zh) 2022-08-30
JP7075359B2 (ja) 2022-05-25
WO2017218454A1 (en) 2017-12-21
CN109641928A (zh) 2019-04-16
ES2988362T3 (es) 2024-11-20
US20190248823A1 (en) 2019-08-15
IL263639A (en) 2019-01-31
BR112018075667A2 (pt) 2019-04-09
MX2018015654A (es) 2019-06-10
US20210269467A1 (en) 2021-09-02
EP3468981B1 (en) 2024-07-24
EP3468981A1 (en) 2019-04-17
US20250011357A1 (en) 2025-01-09
IL263639B (en) 2021-09-30
NZ749360A (en) 2025-11-28
CA3027288A1 (en) 2017-12-21

Similar Documents

Publication Publication Date Title
US20250011357A1 (en) Hydrophobic interaction chromatography for purification of oligonucleotides
JP6571663B2 (ja) 逆方向アプローチを使用した長いrnaの非常に効果的な合成
KR101995521B1 (ko) 역방향 합성 rna를 위한 포스포아미디트
US5811538A (en) Process for the purification of oligomers
JP2015524820A (ja) 重水素化したリボヌクレオシド、n保護ホスホロアミダイト、およびオリゴヌクレオチドの合成
BR112012025872B1 (pt) primidinas modificadas na posição-5
JPH05505197A (ja) 2’―0―アルキルヌクレオチド並びにこのようなヌクレオチドを含むポリマー
CN1643145A (zh) 寡核苷酸及其类似物的纯化方法
US20220363711A1 (en) Purification methods for carbohydrate-linked oligonucleotides
JP2019518759A5 (cg-RX-API-DMAC7.html)
EP2951191A2 (en) Method of preparing oligomeric compounds using modified coupling protocols
JP2022500025A (ja) グアニンリッチオリゴヌクレオチドのための精製方法
JPH06503356A (ja) ホスホロチオエートオリゴヌクレオチドのクロマトグラフィー分離
CA3027288C (en) Hydrophobic interaction chromatography for purification of oligonucleotides
JP2022537182A (ja) オリゴヌクレオチドを脱保護するための方法
EA040914B1 (ru) Хроматография гидрофобного взаимодействия для очистки олигонуклеотидов
HK40007119B (en) Hydrophobic interaction chromatography for purification of oligonucleotides
HK40007119A (en) Hydrophobic interaction chromatography for purification of oligonucleotides
Srivastava et al. RNA Synthesis by Reverse Direction Process: Phosphoramidites and High Purity RNAs and Introduction of Ligands, Chromophores, and Modifications at 3′‐End
BR112021026636B1 (pt) Processo para a purificação de oligonucleotídeos
CN115315430A (zh) 使用了链段型亚磷酰胺化合物的核酸合成法
Kumar Nucleic Acids

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: A CLASSIFICACAO ANTERIOR ERA: C07H 1/00

Ipc: B01D 15/30 (2006.01), B01D 15/32 (2006.01), B01D 1

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B09X Republication of the decision to grant [chapter 9.1.3 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/06/2017, OBSERVADAS AS CONDICOES LEGAIS